Meloxivet 4 John Martin
Meloxicam exerts potent, selective inhibitory activity on Cyclooxygenase-2 (COX-2), both in vivo and in vitro, within the prostaglandin biosynthetic cascade. This selective and specific COX-2 blockade has demonstrated anti-inflammatory, analgesic, anti-exudative, and antipyretic properties, with minimal gastrolesive or ulcerogenic effects.
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
DIFFERENTIATORS
BENEFITS AND COMPETITIVE ADVANTAGES
Fewer tablets needed per dose.
Ideal for medium- and large-breed patients.
Fewer tablets needed per dose.
Flavoured tablets.
TECHNICAL DETAILS
Information
COMPOSITION
– Excipients q.s. for 1 tablet.
DOSAGE AND ADMINISTRATION
Dogs: loading dose of 0.2 mg/kg on the first day. Then administer 0.1 mg/kg every 24 hours.
Cats: 0.1 mg/kg/24 hours for 3 to 5 days, then 0.1 mg total every 24-72 hours.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
- Joint Health
- Opioid Pain Management
- NSAID Pain Management
- Neuropathic Pain
- Steroidal Anti-inflammatory Drugs
- Antibiotics
- Gastrointestinal Health
- Hepatic Health
- Integrative Functional Supplementation
- Vitamins and Minerals
- Omega
- Laxatives
- Anticholinergic – Antispasmodics
- Hemostatic Agents
- Internal Antiparasitics
- External Antiparasitics
- Hemostatic Agent
Meloxivet 4 John Martin
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
Meloxicam exerts potent, selective inhibitory activity on Cyclooxygenase-2 (COX-2), both in vivo and in vitro, within the prostaglandin biosynthetic cascade. This selective and specific COX-2 blockade has demonstrated anti-inflammatory, analgesic, anti-exudative, and antipyretic properties, with minimal gastrolesive or ulcerogenic effects.
Fewer tablets needed per dose.
Ideal for medium- and large-breed patients.
Fewer tablets needed per dose.
Flavoured tablets.
TECHNICAL DETAILS
Information
COMPOSITION
– Excipients q.s. for 1 tablet.
DOSAGE AND ADMINISTRATION
Dogs: loading dose of 0.2 mg/kg on the first day. Then administer 0.1 mg/kg every 24 hours.
Cats: 0.1 mg/kg/24 hours for 3 to 5 days, then 0.1 mg total every 24-72 hours.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
